BioCentury
ARTICLE | Distillery Therapeutics

Pulmonary

November 6, 2017 8:32 PM UTC

Patient sample, mouse and cell culture studies suggest inhibiting miR-34a could help treat BPD and acute lung injury (ALI) in neonates. In postmortem lung tissue samples from premature infants with BP...

BCIQ Company Profiles

Yale University

BCIQ Target Profiles

MicroRNA-34a (miR-34a)